Stay updated with breaking news from Nasdaq Fold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) CEO Bradley L. Campbell sold 15,833 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $14.23, for a total transaction of $225,303.59. Following the transaction, the chief executive officer now owns 947,805 shares of the […]
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The […]
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price target among […]
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) Chairman John F. Crowley sold 6,043 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $11.08, for a total transaction of $66,956.44. Following the completion of the sale, the chairman now directly owns 883,791 shares […]
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) Chairman John F. Crowley sold 6,043 shares of the firm’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $11.08, for a total transaction of $66,956.44. Following the completion of the transaction, the chairman now directly owns […]